Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Weber

Showing results (181-190 of 341) with videos related to

Pageof 35
Sort By:
European Heart Journal|November 22, 2015
Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trialGiuseppe Mancia, Sverre E Kjeldsen, Dion H Zappe, et al.
Journal of Hypertension|January 16, 2018
A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertensionWilliam C Cushman, George L Bakris, William B White, et al.
The American Journal of Medicine|September 4, 2012
Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomilGeorge L Bakris, Domenic Sica, William B White, et al.
Blood Pressure Monitoring|April 17, 2014
Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention studyConrado J Estol, Philip M W Bath, Philip B Gorelick, et al.
Journal of the American Society of Hypertension : JASH|April 20, 2010
ASH position paper: dietary approaches to lower blood pressureLawrence J Appel, Thomas D Giles, Henry R Black, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Expanding the definition and classification of hypertensionThomas D Giles, Bradford C Berk, Henry R Black, et al.
Contemporary Clinical Trials Communications|July 14, 2021
A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptionsMichael Böhm, Martin Fahy, Graeme L Hickey, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2021
Building research capacity within cardiovascular disease prevention and management in low- and middle-income countries: A collaboration of the US Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension LeagueDinesh Neupane, Laura K Cobb, Bethany Hall, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2004
Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trialJoel M Neutel, Michael A Weber, Stevo Julius, et al.
American Heart Journal|December 25, 2015
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medicationsDavid E Kandzari, Kazuomi Kario, Felix Mahfoud, et al.
Pageof 35

Showing results (181-190 of 341) with videos related to

Sort By:
Pageof 35
European Heart Journal|November 22, 2015
Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trialGiuseppe Mancia, Sverre E Kjeldsen, Dion H Zappe, et al.
Journal of Hypertension|January 16, 2018
A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertensionWilliam C Cushman, George L Bakris, William B White, et al.
The American Journal of Medicine|September 4, 2012
Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomilGeorge L Bakris, Domenic Sica, William B White, et al.
Blood Pressure Monitoring|April 17, 2014
Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention studyConrado J Estol, Philip M W Bath, Philip B Gorelick, et al.
Journal of the American Society of Hypertension : JASH|April 20, 2010
ASH position paper: dietary approaches to lower blood pressureLawrence J Appel, Thomas D Giles, Henry R Black, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
Expanding the definition and classification of hypertensionThomas D Giles, Bradford C Berk, Henry R Black, et al.
Contemporary Clinical Trials Communications|July 14, 2021
A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptionsMichael Böhm, Martin Fahy, Graeme L Hickey, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2021
Building research capacity within cardiovascular disease prevention and management in low- and middle-income countries: A collaboration of the US Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension LeagueDinesh Neupane, Laura K Cobb, Bethany Hall, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 29, 2004
Clinical experience with perindopril in elderly hypertensive patients: a subgroup analysis of a large community trialJoel M Neutel, Michael A Weber, Stevo Julius, et al.
American Heart Journal|December 25, 2015
The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medicationsDavid E Kandzari, Kazuomi Kario, Felix Mahfoud, et al.
Pageof 35